# HEPARIN SODIUM IN SODIUM CHLORIDE

NDC: 0338-0431
Generic name: HEPARIN SODIUM
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 19820428

FDA application: NDA018609

## Active ingredients

- HEPARIN SODIUM: 200 [USP'U]/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-0431"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-0431
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d929726-76c3-48fc-b4e7-fd06409f9fb3